Cargando…

State alignment with federal regulations in 2022 to relax buprenorphine 30-patient waiver requirements

BACKGROUND: In 2021, the Department of Health and Human Services released guidelines allowing waiver-eligible providers seeking to treat up to 30 patients to be exempt from waiver training (WT) and the counseling and other ancillary services (CAS) attestation. This study evaluates if states and the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Silwal, Anita, Talbert, Jeffery, Bohler, Robert M., Kelsch, Jordan, Cook, Christopher, Blevins, Derek, Gallivan, Molly, Hunt, Timothy, Hatcher, Sarah M., Thomas, Cindy Parks, Williams, Soncere, Fanucchi, Laura, Lofwall, Michelle R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2023
Materias:	Full Length Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10206439/ https://www.ncbi.nlm.nih.gov/pubmed/37234704 http://dx.doi.org/10.1016/j.dadr.2023.100164

Ejemplares similares

The policy landscape for naloxone distribution in four states highly impacted by fatal opioid overdoses
por: Bohler, Robert M., et al.
Publicado: (2022)

Analysis of US County Characteristics and Clinicians With Waivers to Prescribe Buprenorphine After Changes in Federal Education Requirements
por: Nguyen, Thuy, et al.
Publicado: (2022)

Monthly Patient Volumes of Buprenorphine-Waivered Clinicians in the US
por: Duncan, Alexandra, et al.
Publicado: (2020)

Buprenorphine Waiver Attitudes Among Primary Care Providers
por: Lai, Benjamin, et al.
Publicado: (2022)

Evaluating buprenorphine prescribing and opioid-related health outcomes following the expansion the buprenorphine waiver program
por: Rowe, Christopher L., et al.
Publicado: (2022)

Telemedicine Buprenorphine Initiation and Retention in Opioid Use Disorder Treatment for Medicaid Enrollees
por: Hammerslag, Lindsey R., et al.
Publicado: (2023)

Association of Buprenorphine-Waivered Physician Supply With Buprenorphine Treatment Use and Prescription Opioid Use in Medicaid Enrollees
por: Wen, Hefei, et al.
Publicado: (2018)

Changes in US Clinician Waivers to Prescribe Buprenorphine Management for Opioid Use Disorder During the COVID-19 Pandemic and After Relaxation of Training Requirements
por: Spetz, Joanne, et al.
Publicado: (2022)

Variations in national availability of waivered buprenorphine prescribers by racial and ethnic composition of zip codes
por: Hirchak, Katherine A., et al.
Publicado: (2022)

Survey of Barriers and Facilitators to Prescribing Buprenorphine and Clinician Perceptions on the Drug Addiction Treatment Act of 2000 Waiver
por: Lanham, Holly J., et al.
Publicado: (2022)

Characteristics and Prescribing Patterns of Clinicians Waivered to Prescribe Buprenorphine for Opioid Use Disorder Before and After Release of New Practice Guidelines
por: Jones, Christopher M., et al.
Publicado: (2023)

Emergency-department initiated buprenorphine: Impact on quality of life
por: Carroll, Caleb, et al.
Publicado: (2023)

Implementation of Federal Waivers for Feeding Children in Early Care and Education During the COVID-19 Pandemic
por: Dev, Dipti A., et al.
Publicado: (2022)

The introduction of a novel formulation of buprenorphine into organized health systems()()
por: Mullen, William, et al.
Publicado: (2022)

Hospitalist perspectives on buprenorphine treatment for inpatients with opioid use disorder
por: Reed, Megan K, et al.
Publicado: (2022)

Patient-reported problems filling buprenorphine prescriptions and motivations for illicit use
por: Winstanley, Erin L., et al.
Publicado: (2022)

Design and protocol of the Buprenorphine plus Outpatient Parenteral Antimicrobial Therapy (B-OPAT) study: a randomized clinical trial of integrated outpatient treatment of opioid use disorder and severe, injection-related infections
por: Fanucchi, Laura C., et al.
Publicado: (2022)

Get waivered remote: Nationwide, remote DEA-x waiver course in response to COVID-19
por: Martin, Alister, et al.
Publicado: (2021)

Deuterated buprenorphine retains pharmacodynamic properties of buprenorphine and resists metabolism to the active metabolite norbuprenorphine in rats
por: Janganati, Venumadhav, et al.
Publicado: (2023)

A mixed methods study of HIV-related services in buprenorphine treatment
por: Knudsen, Hannah K., et al.
Publicado: (2017)

A Descriptive Study on Opioid Misuse Prevalence and Office-Based Buprenorphine Access in Ohio Prior to the Removal of the Drug Addiction Treatment Act of 2000 Waiver
por: McKnight, Erin R, et al.
Publicado: (2023)

Association of Naloxone Coprescription Laws With Naloxone Prescription Dispensing in the United States
por: Sohn, Minji, et al.
Publicado: (2019)

Changes in buprenorphine visits in frontier and remote locations: Effects of the SARS-CoV-2 pandemic
por: McFadden, Lisa M.
Publicado: (2023)

Psychiatric comorbidities and their treatment predict buprenorphine continuation among postpartum people with opioid use disorder
por: Shadowen, Hannah, et al.
Publicado: (2022)

Home and Community-Based Services Waivers
por: Duckett, Mary Jean, et al.
Publicado: (2000)

1635. Do Persons With Opioid Use Disorder and Injection-Related Infections Really Need Prolonged Hospitalizations to Complete Intravenous Antibiotic Therapy?
por: Fanucchi, Laura, et al.
Publicado: (2018)

Buprenorphine for Medication-Assisted Treatment of Opioid Use Disorder in Pregnancy: Relationship to Neonatal Opioid Withdrawal Syndrome
por: Chavan, Niraj R., et al.
Publicado: (2017)

Impact of COVID-19-related regulatory changes on nationwide access to buprenorphine: An interrupted time series design
por: Roy, Payel Jhoom, et al.
Publicado: (2023)

Co-occurring psychiatric disorders and disparities in buprenorphine utilization in opioid use disorder: An analysis of insurance claims
por: Xu, Kevin Y, et al.
Publicado: (2023)

Receipt and duration of buprenorphine treatment during pregnancy and postpartum periods in a national privately-insured cohort
por: Wang, Xi, et al.
Publicado: (2023)

Complexity of linear relaxations in integer programming
por: Averkov, Gennadiy, et al.
Publicado: (2021)

State Health Reform and the Role of 1115 Waivers
por: Riley, Trish
Publicado: (1995)

Impact of the Maine Medicaid waiver for the mentally retarded
por: Coburn, Andrew F., et al.
Publicado: (1990)

Clinical trials waiver in India-some considerations
por: Juneja, Atul, et al.
Publicado: (2018)

Impact of reduced restrictions on buprenorphine prescribing during COVID-19 among patients in a community-based treatment program
por: Ward, Kathleen M., et al.
Publicado: (2022)

Buprenorphine involvement in opioid overdose deaths: A retrospective analysis of postmortem toxicology in Marion County, Indiana, 2015-2021
por: del Pozo, Brandon, et al.
Publicado: (2023)

Sex specific effects of buprenorphine on behavior, astrocytic opioid receptor expression and neuroinflammation after pediatric traumatic brain injury in mice
por: Hamood, Yesmine, et al.
Publicado: (2022)

Machine Readable Passports & The Visa Waiver Programme
Publicado: (2003)

Trends and Issues in the Medicaid 1915(c) Waiver Program
por: Miller, Nancy A., et al.
Publicado: (1999)

Impact of municipal health services Medicare waiver program
por: Fleming, Gretchen V., et al.
Publicado: (1987)

Cannot write session to /tmp/vufind_sessions/sess_egc7mua3dvja4vktk7vni2b57a